PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Intelligent Nanohybrid Materials Laboratory (INML), Institute of Tissue Regeneration Engineering (ITREN), Dankook University, Cheonan, 31116, Republic of Korea.\', \'R&D Center, CnPharm Co., LTD., Seoul, 03759, Republic of Korea.\', \'Intelligent Nanohybrid Materials Laboratory (INML), Institute of Tissue Regeneration Engineering (ITREN), Dankook University, Cheonan, 31116, Republic of Korea; College of Science and Technology, Dankook University, Cheonan, 31116, Republic of Korea; Department of Nanobiomedical Science and BK21 PLUS NBM Global Research Center for Regenerative Medicine, Dankook University, Cheonan, 31116, Republic of Korea. Electronic address: goeun.choi@dankook.ac.kr.\', \'Intelligent Nanohybrid Materials Laboratory (INML), Institute of Tissue Regeneration Engineering (ITREN), Dankook University, Cheonan, 31116, Republic of Korea; Department of Pre-Medical Course, College of Medicine, Dankook University, Cheonan, 31116, Republic of Korea; Tokyo Tech World Research Hub Initiative (WRHI), Institute of Innovative Research, Tokyo Institute of Technology, Yokohama, 226-8503, Japan. Electronic address: jhchoy@dankook.ac.kr.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0927-7765(21)00507-510.1016/j.colsurfb.2021.112063
?:hasPublicationType
?:journal
  • Colloids and surfaces. B, Biointerfaces
is ?:pmid of
?:pmid
?:pmid
  • 34482191
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Injectable niclosamide nanohybrid as an anti-SARS-CoV-2 strategy.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all